Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

2(33.3%)

Phase 1

1(16.7%)

Phase 4

1(16.7%)

Phase 3

1(16.7%)

Phase 2

1(16.7%)

6Total

N/A(2)

Phase 1(1)

Phase 4(1)

Phase 3(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07388953Not ApplicableRecruiting

Peripheral Autonomic Block (BAP) Plus Transversus Abdominis Plane Block (TAP) for Postoperative Analgesia After Minimally Invasive Left-Sided Colorectal Resection (BAPTAP)

Role: collaborator

NCT04561219Phase 2Completed

Nitazoxanide Therapy for Patients With COVID-19 Pneumonia

Role: collaborator

NCT03206983Not ApplicableCompleted

Efficacy of the Canabrava/s Pupil Expansion Device in Cataract Surgery With Small Pupils: The First 30 Cases

Role: lead

NCT02233452Phase 4Completed

Methadone and Ketamine for Neuropathic Pain Treatment

Role: collaborator

NCT01083797Phase 3Completed

Sedation to Electroencephalography With Dexmedetomidine or Chloral Hydrate

Role: collaborator

NCT01130610Completed

Pre-anesthetic Evaluation and Cost Reduction

Role: lead

NCT00672347Phase 1Completed

Clonidine and Morphine in Caudal Anesthesia

Role: collaborator

All 7 trials loaded